Refine by
Pancreas Disease Suppliers & Manufacturers
7 companies found
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
RIPK3-IN-1 is a RIPK3 type II DFG-out inhibitor with an IC50 of 9.1 nM. RIPK3-IN-1 inhibits RIPK1 and RIPK2 with IC50s of 5.5 and >10 μM. RIPK3-IN-1 is also a c-Met kinase inhibitor with an IC50 of 1.1 ...
based inBuk-gu, SOUTH KOREA
JD Bioscience (JDB) is a group of experts in small molecule-based novel drug development. JD Bioscience was established by a team of highly experienced medicinal chemists, biologists, and clinicians in the field of endocrine and metabolic diseases. ...
based inDavis, CALIFORNIA (USA)
For over fifty years, the people of Antibodies Incorporated have dedicated themselves to supporting the life-enhancing, breakthrough work of scientists everywhere. We fulfill our mission with an extensive catalog of validated neuroscience antibodies ...
Immunoblot against crude membrane fractions from whole mouse (MBM) or rat (RBM) brain and from human cerebral cortex [HBM(Cx)] or hippocampus [HBM(H)] and probed with K91/36 (left) or N52A/42 (right) TC ...
based inOxford, UNITED KINGDOM
Perspectum delivers cutting-edge digital technologies that help clinicians provide better care for patients with liver disease, diabetes, and cancer. With a strong focus on precision medicine using advanced imaging and genetics, our vision is to ...
based inDurham, NORTH CAROLINA (USA)
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable, bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. Humacyte ...
based inRye Brook, NEW YORK (USA)
Curemark is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Our pipeline includes our lead drug candidate, CM-AT, which is in a Phase III clinical trial for Autism, and is ...
Patient-centered drug discovery is at the core of what we do at Curemark. We approach neurological disorders from a translational and innovative ...
based inBergen, NORWAY
Benchmark Genetics is a leader in aquaculture genetics, present in every major aquaculture market and for a wide range of species. Our five in-house breeding programmes are focusing on three main species: salmon, shrimp and tilapia. We are the ...